60 Degrees Pharmaceuticals (SCTP) Proxy Filing summary

Executive summary

• Special Meeting scheduled for November 6, 2024, to be held virtually, with voting accessible online for all stockholders of record as of September 20, 2024.

• Proxy materials are distributed primarily via the internet to expedite delivery, reduce costs, and conserve resources.

• Four main proposals will be presented: approval of warrant exercises, amendment to the equity incentive plan, reverse stock split, and potential adjournment to solicit more proxies.

• Board recommends voting "FOR" all proposals, citing their importance for corporate flexibility and compliance.

Voting matters and shareholder proposals

• Proposal 1: Approve exercise of warrants issued on September 5, 2024, for up to 6,014,493 shares, subject to Nasdaq rules.

• Proposal 2: Amend the 2022 Equity Incentive Plan to increase shares available for issuance by 500,000.

• Proposal 3: Approve a reverse stock split at a ratio between 1:3 and 1:5, at the Board's discretion.

• Proposal 4: Approve adjournment of the meeting if more time is needed to solicit votes for the above proposals.

• No other business is currently anticipated for the meeting.

Board of directors and corporate governance

• Board has determined all proposals are in the best interests of the company and stockholders.

• Proxy solicitation is managed by the Board, with expenses covered by the company.

• Stockholder proposals for the 2025 annual meeting must be submitted by April 17, 2025.